Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...

While Prasad’s views may not align with many of the FDA’s traditional policies, they do fit into a broader MAHA agenda of ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...

UnitedHealth Group CEO Andrew Witty abruptly stepped down from the health insurance and care conglomerate on Tuesday, citing ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

Hospitals pay provider taxes, helping states spend more on Medicaid and increase the amounts paid by the federal government.

This is a hectic week, and it got off to an early start with President Trump on Sunday evening breaking the embargo on his ...

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

Biotech investment firm RA Capital has laid off staff at its internal startup incubator, highlighting the instability among ...

US president Donald Trump has announced an executive order aimed at reducing US prescription drug costs by 30-80%. The policy would align US drug prices with the lowest prices paid internationally and ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron ...

Speculation about a takeover play for Cytokinetics isn’t going away, with Amgen the latest company to be linked to the company and its highly-anticipated cardiovascular drug aficamten.